TY - JOUR
T1 - Purification and characterization of 'Trimarin' a hemorrhagic metalloprotease with factor Xa-like Activity, from Trimeresurus malabaricus snake venom
AU - Kumar, R. Venkatesh
AU - Gowda, C. D.Raghavendra
AU - Shivaprasad, Holenarasipura V.
AU - Siddesha, Jalahalli M.
AU - Sharath, B. K.
AU - Vishwanath, Bannikuppe S.
N1 - Funding Information:
This work has been supported by a grant (No. BT/PR4467/NDB/51/031/2003 dated 06.05.2004) from Department of Biotechnology (DBT), Government of India, New Delhi, India. We thank Dr. K. S. Girish, Assistant Professor, Department of Studies in Biochemistry, University of Mysore, Mysore for his valuable suggestions and timely help. We also thank Dr. Rajesh R for kind gift of congenital factor X deficient plasma.
PY - 2010/11
Y1 - 2010/11
N2 - In the present study, we describe the purification and characterization of a metalloprotease 'trimarin' from Trimeresurus malabaricus snake venom. Trimarin is a single-chain basic protein, with a molecular mass of 29.6 kDa. Trimarin showed proteolytic activity towards casein and fibrinogen, which was irreversibly inhibited by EDTA and 1,10-phenanthroline. The metal ion associated with trimarin was found to be Zn2+. Trimarin exhibited pharmacological activities including hemorrhage, myotoxicity, procoagulant and factor Xa-like activities. The hemorrhage and myotoxicity correlated with degradation of extracellular protein components type-IV collagen and fibronectin. Myotoxicity due to muscle tissue necrosis was substantiated with increased serum CK activity. Trimarin showed procoagulant activity with reduced re-calcification time of citrated human plasma. Trimarin shortened the activated partial thromboplastin time (aPTT) and prothrombin time (PT), suggesting its involvement in common pathway of blood coagulation. Trimarin coagulated the citrated human plasma in the absence of CaCl2, but it was lacking thrombin like activity as it did not clot the purified fibrinogen. Remarkably, the enzyme clotted the factor X deficient human plasma, suggesting that trimarin has factor Xa-like activity. Thus, trimarin may play a key role in the pathophysiological conditions that occur during T. malabaricus envenomation, and may be used as a biological tool to explore many facets of hemostasis.
AB - In the present study, we describe the purification and characterization of a metalloprotease 'trimarin' from Trimeresurus malabaricus snake venom. Trimarin is a single-chain basic protein, with a molecular mass of 29.6 kDa. Trimarin showed proteolytic activity towards casein and fibrinogen, which was irreversibly inhibited by EDTA and 1,10-phenanthroline. The metal ion associated with trimarin was found to be Zn2+. Trimarin exhibited pharmacological activities including hemorrhage, myotoxicity, procoagulant and factor Xa-like activities. The hemorrhage and myotoxicity correlated with degradation of extracellular protein components type-IV collagen and fibronectin. Myotoxicity due to muscle tissue necrosis was substantiated with increased serum CK activity. Trimarin showed procoagulant activity with reduced re-calcification time of citrated human plasma. Trimarin shortened the activated partial thromboplastin time (aPTT) and prothrombin time (PT), suggesting its involvement in common pathway of blood coagulation. Trimarin coagulated the citrated human plasma in the absence of CaCl2, but it was lacking thrombin like activity as it did not clot the purified fibrinogen. Remarkably, the enzyme clotted the factor X deficient human plasma, suggesting that trimarin has factor Xa-like activity. Thus, trimarin may play a key role in the pathophysiological conditions that occur during T. malabaricus envenomation, and may be used as a biological tool to explore many facets of hemostasis.
UR - http://www.scopus.com/inward/record.url?scp=78149285062&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78149285062&partnerID=8YFLogxK
U2 - 10.1016/j.thromres.2010.07.025
DO - 10.1016/j.thromres.2010.07.025
M3 - Article
C2 - 20850171
AN - SCOPUS:78149285062
SN - 0049-3848
VL - 126
SP - e356-e364
JO - Thrombosis Research
JF - Thrombosis Research
IS - 5
ER -